Target intelligence / Profile preview

Long intergenic non-protein coding RNA 494 (LINC00494)

Target: LINC00494
Molecular classification: Long non-coding RNA (lncRNA), Intergenic non-coding RNA, Other (non-protein coding RNA)

Overview

Long intergenic non-protein coding RNA 494 (LINC00494) is a long non-coding RNA found to be upregulated in ovarian cancer tissues. It promotes cancer cell migration, invasion, and tumorigenesis primarily by modulating the transcription factor NFκB1, leading to decreased expression of the E3 ubiquitin ligase FBXO32. Experimental knockdown of LINC00494 reverses malignant phenotypes, suggesting it is an oncogenic lncRNA and a potential therapeutic target. Its main molecular classification is as a long non-coding RNA, and its clinical detection may offer value as a diagnostic or prognostic biomarker in ovarian and potentially other cancers

Other names: LINC00494Long intergenic non-coding RNA 494

Mechanism of action

Not applicable for standard drugs, but knockdown of LINC00494 inhibits ovarian cancer cell migration, invasion, and tumorigenesis by regulating the transcription factor NFκB1 and downstream gene FBXO32

Biological functions

Gene expression regulationTranscriptional modulation (via interaction with transcription factors, e.g., NFκB1)Cell proliferationCell migrationCell invasionTumorigenesis

Disease associations

Cancer (especially ovarian cancer)Other cancer types (potential, but most robustly shown for ovarian cancer)

Safety considerations

Not well characterized; as LINC00494 is a non-coding RNA, off-target effects or impact on normal cell biology are theoretical concerns in therapeutic targeting

Biomarkers

Overexpression of LINC00494 (may serve as a prognostic or diagnostic biomarker for ovarian cancer)Upregulated NFκB1 (in connection with LINC00494 activity)Downregulated FBXO32 (inverse correlation with LINC00494 in cancer)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 494 (LINC00494).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 494 (LINC00494).

Explore the full profile